Results 231 to 240 of about 72,471 (294)

Decreased citalopram concentration caused by enzyme induction effect of rifampin: a case report. [PDF]

Ther Adv Psychopharmacol
Liu J, Li J, Zheng R, Zhang R.
europepmc   +1 more source

Odevixibat improves pruritus and bile acid level in Alagille syndrome: A case report. [PDF]

World J Gastrointest Pharmacol Ther
Al Atrash E, Bitar R.
europepmc   +1 more source

Passive Membrane Transport Analysis of Drug Mixtures. [PDF]

Anal Chem
Strutt R, Berlanda SF, Dittrich PS.
europepmc   +1 more source

Limitations of the MTB/RIF Assay: An Xpert Review of 4 Clinical Cases. [PDF]

Open Forum Infect Dis
Haas AL, Ma A, Pham J, Verma P, Malhotra U, Church EC, Narita M, Escuyer V, Shakir SM.   +8 more
europepmc   +1 more source

Rhodococcus equi Endocarditis in Prosthetic Valve of a Heart Transplant Recipient. [PDF]

JACC Case Rep
Guru S, Ali O, Jaafar N, Sharma R, Guru N, Julian K.   +5 more
europepmc   +1 more source

RIFAMPIN IN DERMATOLOGY [PDF]

International Journal of Dermatology, 1993
Rifampicin (Rp) is a semisynthetic derivative of Rifamycin B, an antimicrobial agent produced by Streptomyces mediterranei. Rp is a broad spectrum antimicrobial and inhibits the growth of most Gram-positive bacteria, as well as many Gram-negative microorganisms, such as Escherichia coli, Pseudomonas, indole-positive and indole-negative Proteus, and ...
Nikolai Tsankov, Jivko A. Kamarashev
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Rifampin

Pediatrics In Review, 1996
Rifampin is a semisynthetic derivative of rifamycin B that is active against a wide range of microorganisms and bactericidal for extracellular as well as intracellular pathogens. Most gram-positive and many gram-negative bacteria, as well as mycobactenia, are inhibited by nifampin.
openaire   +2 more sources